Kenneth William Duncan

This inventor holds 50 USPTO granted patents and 39 published patent applications, plus 3 CIPO patents and 16 EPO patents, primarily in PRMT5 Inhibitors. Top assignees: Epizyme, Inc., Accent Therapeutics, Inc., Eisai R&d Management Co., Ltd.. Active years: 2013-2025.

USPTO Granted Patents = 50 (Patent Applications = 39)

% Patents Active = 94.0

CIPO Patents = 3 (Patent Applications = 16)

EPO Patents = 16 (Patent Applications = 24)

Average Co-Inventor Count = 5.2

ph-index = 21

Forward Citations = 994(Granted Patents)

Forward Citations (Not Self Cited) = 630(Dec 10, 2025)

Location History:

Norwood, MA (US) (2013 - 2018)
Westwood, MA (US) (2014 - 2023)

Company Filing History:

Accent Therapeutics, Inc.

patents

1 out of 530

Eisai R&d Management Co., Ltd.

patents

4. 1 out of 242

Glaxosmithkline Intellectual Property Development Limited

patents

5. 1 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2013-2025

Loading Chart...

Areas of Expertise:

PRMT5 Inhibitors

RNA Helicase

Heteroaryl Compounds

Arginine Methyltransferase

Inhibitors

Bicyclic Compounds

Combination Therapies

Acetyltransferase

Aryl Compounds

Pyrazole Derivatives

Tetrahydroisoquinoline

50 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12391709 - Inhibitors of KIF18A and uses thereof (2025-08-19),

2. 12233065 - Inhibitors of RNA helicase DHX9 and uses thereof (2025-02-25),

3. 12168016 - Aryl-OR heteroaryl-substituted benzene compounds (2024-12-17),

4. 12168015 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-17),

5. 12162867 - Inhibitors of RNA helicase DHX9 and uses thereof (2024-12-10),

6. 12161645 - Aryl-or heteroaryl-substituted benzene compounds (2024-12-10),

7. 12116358 - Substituted indoles and methods of use thereof (2024-10-15),

8. 11685732 - MYST family histone acetyltransferase inhibitors (2023-06-27),

9. 11672800 - Combination therapies with EHMT2 inhibitors (2023-06-13),

10. 11052093 - Aryl-or heteroaryl-substituted benzene compounds (2021-07-06),

11. 10980794 - PRMT5 inhibitors and uses thereof (2021-04-20),

12. 10653693 - PRMT5 inhibitors and uses thereof (2020-05-19),

13. 10420775 - Aryl-or heteroaryl-substituted benzene compounds (2019-09-24),

14. 10391089 - PRMT5 inhibitors and uses therof (2019-08-27),

15. 10307413 - Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof (2019-06-04),

Title: Kenneth William Duncan - Pioneering Inventor from Westwood, MA

Introduction: Kenneth William Duncan is a renowned inventor hailing from Westwood, Massachusetts. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various industries through his groundbreaking inventions.

Latest Patents: Kenneth William Duncan holds several patents in the fields of technology and healthcare, with his most recent inventions focusing on sustainable energy solutions and advanced medical devices.

Career Highlights: Throughout his illustrious career, Kenneth William Duncan has been recognized for his innovative spirit and dedication to creating cutting-edge technologies. He has received numerous awards for his contributions to the field of invention and has been a keynote speaker at several prestigious conferences.

Collaborations: Kenneth William Duncan has collaborated with leading research institutions, universities, and companies to bring his inventions to life. His ability to work across disciplines and industries has led to the development of revolutionary products that have had a lasting impact on society.

Conclusion: In conclusion, Kenneth William Duncan's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a pioneering inventor in the world of technology and healthcare. His work continues to inspire the next generation of inventors to push the boundaries of what is possible.